Completed
Tezepelumab PRO Study
NCT05922891
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Research Site Aomori, Japan
- Research Site Bunkyō City, Japan
- Research Site Fujisawa, Japan
- Research Site Fukuoka, Japan